Effects of exercise on inflammation in patients receiving chemotherapy: a nationwide NCORP randomized clinical trial

Ian R Kleckner, Charles Kamen, Calvin Cole, Chunkit Fung, Charles E Heckler, Joseph J Guido, Eva Culakova, Adedayo A Onitilo, Alison Conlin, J Philip Kuebler, Supriya Mohile, Michelle Janelsins, Karen M Mustian, Ian R Kleckner, Charles Kamen, Calvin Cole, Chunkit Fung, Charles E Heckler, Joseph J Guido, Eva Culakova, Adedayo A Onitilo, Alison Conlin, J Philip Kuebler, Supriya Mohile, Michelle Janelsins, Karen M Mustian

Abstract

Purpose: A growing body of research suggests that inflammation plays a role in many chemotherapy-related toxicities such as fatigue, anxiety, and neuropathy. Regular exercise can change levels of individual cytokines (e.g., reducing IL-6, increasing IL-10); however, it is not known whether exercise during chemotherapy affects relationships between cytokines (i.e., whether cytokine concentrations change collectively vs. independently). This study assessed how 6 weeks of exercise during chemotherapy affected relationships between changes in concentrations of several cytokines.

Methods: This is a secondary analysis of a randomized trial studying 6 weeks of moderate-intensity walking and resistance exercise during chemotherapy compared with chemotherapy alone. At pre- and post-intervention, patients provided blood to assess serum concentrations of cytokines IL-1β, IL-6, IL-8, IL-10, and IFN-γ, and receptor sTNFR1. We investigated relationships between cytokines using the correlations between changes in cytokine concentrations from pre- to post-intervention.

Results: We obtained complete data from 293 patients (149 randomized to exercise). Exercise strengthened the correlation between concentration changes of IL-10 and IL-6 (r = 0.44 in exercisers vs. 0.11 in controls; p = 0.001). We observed the same pattern for IL-10:IL-1β and IL-10:sTNFR1. Exercise also induced an anti-inflammatory cytokine profile, per reductions in pro-inflammatory IFN-γ (p = 0.044) and perhaps IL-1β (p = 0.099, trend-level significance).

Conclusions: Our hypothesis-generating work suggests that regular exercise during 6 weeks of chemotherapy may cause certain cytokine concentrations to change collectively (not independently). This work enhances our understanding of relationships between cytokines and complements traditional analyses of cytokines in isolation. Future work should test for replication and relationships to patient outcomes.

Trial registration: Clinical Trials.gov, # NCT00924651, http://www.clinicaltrials.gov .

Keywords: Chemotherapy; Cytokine; Cytokine correlation; Cytokine matrix; Cytokine network; Exercise.

Conflict of interest statement

Conflict of interest statement

The authors have no conflict of interest to declare as the research was voluntarily conducted. The authors have full control of all primary data and agree to allow the journal to review the data if requested.

Figures

Figure 1.
Figure 1.
CONSORT diagram of study participants.
Figure 2.
Figure 2.
Regular exercise during six weeks of chemotherapy increases the correlation between change in IL-6 concentration and change in IL-10 concentration. Each data point shows one participant, with 143 participants randomized to chemotherapy alone (left) and 142 participants randomized to chemotherapy plus exercise (right). Each figure shows the Pearson’s correlation r and the corresponding p-value from a two-tailed test.
Figure 3.
Figure 3.
Regular exercise during six weeks of chemotherapy induces greater correlations among changes in cytokine and receptor concentrations. The network diagram shows the correlation strength between changes in each cytokine or receptor concentration (like the one shown in Figure 2, which involves IL-6 and IL-10). Stronger correlations are shown with thicker lines that vary continuously; positive correlations are red, and negative correlations are blue. Each asterisk (*) indicates that the correlation coefficient differs from zero (p<0.05, two-tailed). Each dagger (†) indicates that the correlation coefficient differs by study arm (p<0.05, two-tailed). These data are also shown in Table 2.
Figure 4.
Figure 4.
Regular exercise during six weeks of chemotherapy induces an anti-inflammatory state, as evidenced by reduction in IFNγ (p=0.044) and perhaps IL1β (p=0.099, trend-level effect). Sample sizes are provided at the bottom of each figure. Each asterisk (*) indicates that the change in cytokine concentration differs from zero within study arm (p<0.05, two-tailed). Each dagger (†) indicates that the change in cytokine concentration differs by study arm (p<0.05, two-tailed). Error bars are standard errors and units are log10(pg/mL).

References

    1. Mustian KM, Sprod LK, Janelsins M, et al. Exercise Recommendations for Cancer-Related Fatigue, Cognitive Impairment, Sleep Problems, Depression, Pain, Anxiety, and Physical Dysfunction—A Review. Oncology & Hematology Review (US) 2012;8(2):81–88.
    1. Pusztai L, Mendoza TR, Reuben JM, et al. Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy. Cytokine 2004;25(3):94–102.
    1. Collado-Hidalgo A, Bower JE, Ganz PA, et al. Inflammatory biomarkers for persistent fatigue in breast cancer survivors. Clin Cancer Res 2006;12(9):2759–66.
    1. Zhou YQ, Liu Z, Liu ZH, et al. Interleukin-6: an emerging regulator of pathological pain. J Neuroinflammation 2016;13(1):141.
    1. Janelsins MC, Kesler SR, Ahles TA, et al. Prevalence, mechanisms, and management of cancer-related cognitive impairment. Int Rev Psychiatry 2014;26(1):102–13.
    1. Bower JE, Lamkin DM. Inflammation and cancer-related fatigue: mechanisms, contributing factors, and treatment implications. Brain Behav Immun 2013;30 Suppl:S48–57.
    1. Wang XM, Lehky TJ, Brell JM, et al. Discovering cytokines as targets for chemotherapy-induced painful peripheral neuropathy. Cytokine 2012;59(1):3–9.
    1. McNeely ML, Parliament MB, Seikaly H, et al. Effect of exercise on upper extremity pain and dysfunction in head and neck cancer survivors: a randomized controlled trial. Cancer 2008;113(1):214–22.
    1. Segal RJ, Reid RD, Courneya KS, et al. Resistance exercise in men receiving androgen deprivation therapy for prostate cancer. J Clin Oncol 2003;21(9):1653–9.
    1. Mustian KM, Alfano CM, Heckler C, et al. A Comparative Meta-Analysis of Pharmaceutical, Psychological, and Exercise Treatments for Cancer-Related Fatigue. JAMA Oncology 2017.
    1. Kleckner IR, Kamen C, Gewandter JS, et al. Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial. Support Care Cancer 2018;26(4):1019–1028.
    1. Kleckner IR, Kamen C, Gewandter JS, et al. Response to Crevenna and Ashbury, Vallance and Bolam, and Crevenna and Keilani regarding the effects of exercise on chemotherapy-induced peripheral neuropathy. Support Care Cancer 2019;27(1):7–8.
    1. Kleckner IR, Dunne RF, Asare M, et al. Exercise for Toxicity Management in Cancer-A Narrative Review. Oncol Hematol Rev 2018;14(1):28–37.
    1. Gleeson M, Bishop NC, Stensel DJ, et al. The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease. Nat Rev Immunol 2011;11(9):607–15.
    1. Troseid M, Lappegard KT, Claudi T, et al. Exercise reduces plasma levels of the chemokines MCP-1 and IL-8 in subjects with the metabolic syndrome. Eur Heart J 2004;25(4):349–55.
    1. Baum M, Muller-Steinhardt M, Liesen H, et al. Moderate and exhaustive endurance exercise influences the interferon-gamma levels in whole-blood culture supernatants. Eur J Appl Physiol Occup Physiol 1997;76(2):165–9.
    1. Mills PJ, Parker B, Dimsdale JE, et al. The relationship between fatigue and quality of life and inflammation during anthracycline-based chemotherapy in breast cancer. Biol Psychol 2005;69(1):85–96.
    1. Mommersteeg PM, Kupper N, Schoormans D, et al. Health-related quality of life is related to cytokine levels at 12 months in patients with chronic heart failure. Brain Behav Immun 2010;24(4):615–22.
    1. Zimmer P, Baumann FT, Bloch W, et al. Impact of exercise on pro inflammatory cytokine levels and epigenetic modulations of tumor-competitive lymphocytes in Non-Hodgkin-Lymphoma patients-randomized controlled trial. Eur J Haematol 2014;93(6):527–32.
    1. Rogers LQ, Vicari S, Trammell R, et al. Biobehavioral factors mediate exercise effects on fatigue in breast cancer survivors. Med Sci Sports Exerc 2014;46(6):1077–88.
    1. Gomez AM, Martinez C, Fiuza-Luces C, et al. Exercise training and cytokines in breast cancer survivors. Int J Sports Med 2011;32(6):461–7.
    1. Schindler R, Mancilla J, Endres S, et al. Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF. Blood 1990;75(1):40–7.
    1. Alexandrakis MG, Roussou P, Pappa CA, et al. Relationship between circulating BAFF serum levels with proliferating markers in patients with multiple myeloma. Biomed Res Int 2013;2013:389579.
    1. Labidi SI, Menetrier-Caux C, Chabaud S, et al. Serum cytokines in follicular lymphoma. Correlation of TGF-beta and VEGF with survival. Ann Hematol 2010;89(1):25–33.
    1. Dhabhar FS, Burke HM, Epel ES, et al. Low serum IL-10 concentrations and loss of regulatory association between IL-6 and IL-10 in adults with major depression. J Psychiatr Res 2009;43(11):962–9.
    1. Berg A, Patel S, Gonca M, et al. Cytokine network in adults with falciparum Malaria and HIV-1: increased IL-8 and IP-10 levels are associated with disease severity. PLoS One 2014;9(12):e114480.
    1. Pripp AH, Stanisic M. The correlation between pro- and anti-inflammatory cytokines in chronic subdural hematoma patients assessed with factor analysis. PLoS One 2014;9(2):e90149.
    1. Horsburgh S, Robson-Ansley P, Adams R, et al. Exercise and inflammation-related epigenetic modifications: focus on DNA methylation. Exerc Immunol Rev 2015;21:26–41.
    1. Marcus BH, Selby VC, Niaura RS, et al. Self-efficacy and the stages of exercise behavior change. Res Q Exerc Sport 1992;63(1):60–6.
    1. Schmitz KH, Courneya KS, Matthews C, et al. American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc 2010;42(7):1409–26.
    1. Mustian K, Janelsins M, Peppone L, et al. EXCAP exercise effects on cognitive impairment and inflammation: A URCC NCORP RCT in 479 cancer patients. In: American Society for Clinical Oncology Annual Meeting Chicago, IL, 2015.
    1. American College of Sports Medicine. ACSM’s Guidelines for exercise testing and prescription Baltimore, MD: Lippincott, Williams, & Wilkins; 2010.
    1. Cavaillon JM. Pro- versus anti-inflammatory cytokines: myth or reality. Cell Mol Biol (Noisy-le-grand) 2001;47(4):695–702.
    1. Bender R, Lange S. Adjusting for multiple testing--when and how? J Clin Epidemiol 2001;54(4):343–9.
    1. Uh HW, Hartgers FC, Yazdanbakhsh M, et al. Evaluation of regression methods when immunological measurements are constrained by detection limits. BMC Immunol 2008;9:59.
    1. van Buuren S, Groothuis-Oudshoorn K. MICE: Multivariate imputation by chained equations in R. Journal of Statistical Software 2011;45(3).
    1. Leggate M, Nowell MA, Jones SA, et al. The response of interleukin-6 and soluble interleukin-6 receptor isoforms following intermittent high intensity and continuous moderate intensity cycling. Cell Stress Chaperones 2010;15(6):827–33.
    1. Christensen JF, Tolver A, Andersen JL, et al. Resistance training does not protect against increases in plasma cytokine levels among germ cell cancer patients during and after chemotherapy. J Clin Endocrinol Metab 2014;99(8):2967–76.
    1. Allgayer H, Nicolaus S, Schreiber S. Decreased interleukin-1 receptor antagonist response following moderate exercise in patients with colorectal carcinoma after primary treatment. Cancer Detect Prev 2004;28(3):208–13.
    1. Monastero RN, Pentyala S. Cytokines as Biomarkers and Their Respective Clinical Cutoff Levels. Int J Inflam 2017;2017:4309485.
    1. Koksal D, Unsal E, Poyraz B, et al. The value of serum interferon-gamma level in the differential diagnosis of active and inactive pulmonary tuberculosis. Tuberk Toraks 2006;54(1):17–21.
    1. Dinarello CA. Historical insights into cytokines. Eur J Immunol 2007;37 Suppl 1:S34–45.
    1. Hui D, Glitza I, Chisholm G, et al. Attrition rates, reasons, and predictive factors in supportive care and palliative oncology clinical trials. Cancer 2013;119(5):1098–105.
    1. Henneghan AM, Palesh O, Harrison M, et al. Identifying cytokine predictors of cognitive functioning in breast cancer survivors up to 10years post chemotherapy using machine learning. J Neuroimmunol 2018;320:38–47.
    1. Loprinzi CL, Reeves BN, Dakhil SR, et al. Natural history of paclitaxel-associated acute pain syndrome: prospective cohort study NCCTG N08C1. J Clin Oncol 2011;29(11):1472–8.

Source: PubMed

3
Subscribe